The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Current prospects for RNA interference-based therapies
Open accessAbstract
RNA interference (RNAi) is a powerful approach for reducing expression of endogenously expressed proteins. It is widely used for biological applications and is being harnessed to silence mRNAs encoding pathogenic proteins for therapy. Various methods — including delivering RNA oligonucleotides and expressing RNAi triggers from viral vectors — have been developed for successful RNAi in cell culture and in vivo. Recently, RNAi-based gene silencing approaches have been demonstrated in humans, and ongoing clinical trials hold promise for treating fatal disorders or providing alternatives to traditional small molecule therapies. Here we describe the broad range of approaches to achieve targeted gene silencing for therapy, discuss important considerations when developing RNAi triggers for use in humans, and review the current status of clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Prediction of Mammalian MicroRNA Targets
Lewis, B. P., Shih, I.-H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003) · Cell · doi:10.1016/s0092-8674(03)01018-3 · Cited by 5,199
The nuclear RNase III Drosha initiates microRNA processing
Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Rådmark, O., Kim, S., et al. (2003) · Nature · doi:10.1038/nature01957 · Cited by 5,114
Role for a bidentate ribonuclease in the initiation step of RNA interference
Bernstein, E., Caudy, A. A., Hammond, S. M., & Hannon, G. J. (2001) · Nature · doi:10.1038/35053110 · Cited by 4,892
The widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Mammalian microRNAs predominantly act to decrease target mRNA levels
Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886
RNA interference is mediated by 21- and 22-nucleotide RNAs
Elbashir, S. M., Lendeckel, W., & Tuschl, T. (2001) · Genes & Development · doi:10.1101/gad.862301 · Cited by 3,310
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs
Yi, R., Qin, Y., Macara, I. G., & Cullen, B. R. (2003) · Genes & Development · doi:10.1101/gad.1158803 · Cited by 3,010
Asymmetry in the Assembly of the RNAi Enzyme Complex
Schwarz, D. S., Hutvágner, G., Du, T., Xu, Z., Aronin, N., & Zamore, P. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00759-1 · Cited by 2,922
The Microprocessor complex mediates the genesis of microRNAs
Gregory, R. I., Yan, K.-P., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch, N., & Shiekhattar, R. (2004) · Nature · doi:10.1038/nature03120 · Cited by 2,742
Nuclear Export of MicroRNA Precursors
Lund, E., Güttinger, S., Calado, A., Dahlberg, J. E., & Kutay, U. (2004) · Science · doi:10.1126/science.1090599 · Cited by 2,714
Zamore, P. D., Tuschl, T., Sharp, P. A., & Bartel, D. P. (2000) · Cell · doi:10.1016/s0092-8674(00)80620-0 · Cited by 2,676
Functional siRNAs and miRNAs exhibit strand bias
Khvorova, A., Reynolds, A., & Jayasena, S. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00801-8 · Cited by 2,645
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Expression profiling reveals off-target gene regulation by RNAi
Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370
Small silencing RNAs: an expanding universe
Ghildiyal, M., & Zamore, P. D. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2504 · Cited by 2,325
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells
Ebert, M. S., Neilson, J. R., & Sharp, P. A. (2007) · Nature Methods · doi:10.1038/nmeth1079 · Cited by 2,108
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · cited 2×
“For example, using 2′-O-methyl-modified purine nucleosides in the passenger strand reduces IFN induction but retains targeting specificity [38] [39] [40] .”
BackgroundMethodFatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
Lanford, R. E., Hildebrandt-Eriksen, E. S., Petri, A., Persson, R., Lindow, M., Munk, M. E., Kauppinen, S., & Ørum, H. (2010) · Science · doi:10.1126/science.1178178 · Cited by 1,459
RNA polymerase III transcribes human microRNAs
Borchert, G. M., Lanier, W., & Davidson, B. L. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1167 · Cited by 1,393
Self-citationRNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357 · cited 1×
“Data from rodents and nonhuman primates 50, 122 show significant LDL-lowering properties and, in one of the first trials in humans, corporate news releases stated that the SNALP-formulated APOB siRNA was well tolerated at all but the highest dose.”
BackgroundRelief of microRNA-Mediated Translational Repression in Human Cells Subjected to Stress
Bhattacharyya, S. N., Habermacher, R., Martine, U., Closs, E. I., & Filipowicz, W. (2006) · Cell · doi:10.1016/j.cell.2006.04.031 · Cited by 1,332
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250
Transvascular delivery of small interfering RNA to the central nervous system
Kumar, P., Wu, H., McBride, J. L., Jung, K.-E., Hee Kim, M., Davidson, B. L., Kyung Lee, S., Shankar, P., & Manjunath, N. (2007) · Nature · doi:10.1038/nature05901 · Cited by 1,246
Self-citationHornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A., Manoharan, M., Akira, S., de Fougerolles, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1191 · Cited by 1,232
Passenger-Strand Cleavage Facilitates Assembly of siRNA into Ago2-Containing RNAi Enzyme Complexes
Matranga, C., Tomari, Y., Shin, C., Bartel, D. P., & Zamore, P. D. (2005) · Cell · doi:10.1016/j.cell.2005.08.044 · Cited by 1,211
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168
Strategies for silencing human disease using RNA interference
Kim, D. H., & Rossi, J. J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2006 · Cited by 1,078
RNA interference in adult mice
McCaffrey, A. P., Meuse, L., Pham, T.-T. T., Conklin, D. S., Hannon, G. J., & Kay, M. A. (2002) · Nature · doi:10.1038/418038a · Cited by 1,059
ATP Requirements and Small Interfering RNA Structure in the RNA Interference Pathway
Nykänen, A., Haley, B., & Zamore, P. D. (2001) · Cell · doi:10.1016/s0092-8674(01)00547-5 · Cited by 1,016
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1339 · Cited by 974
Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity
Jackson, A. L., Burchard, J., Schelter, J., Chau, B. N., Cleary, M., Lim, L., & Linsley, P. S. (2006) · RNA · doi:10.1261/rna.25706 · Cited by 956
P bodies: at the crossroads of post-transcriptional pathways
Eulalio, A., Behm-Ansmant, I., & Izaurralde, E. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2080 · Cited by 936
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Kleinman, M. E., Yamada, K., Takeda, A., Chandrasekaran, V., Nozaki, M., Baffi, J. Z., Albuquerque, R. J. C., Yamasaki, S., Itaya, M., Pan, Y., et al. (2008) · Nature · doi:10.1038/nature06765 · Cited by 929
Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges
Mingozzi, F., & High, K. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2988 · Cited by 893
Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy
Kim, D.-H., Behlke, M. A., Rose, S. D., Chang, M.-S., Choi, S., & Rossi, J. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1051 · Cited by 884
siRNA-mediated gene silencing in vitro and in vivo
Xia, H., Mao, Q., Paulson, H. L., & Davidson, B. L. (2002) · Nature Biotechnology · doi:10.1038/nbt739 · Cited by 873
Self-citationInterferon modulation of cellular microRNAs as an antiviral mechanism
Pedersen, I. M., Cheng, G., Wieland, S., Volinia, S., Croce, C. M., Chisari, F. V., & David, M. (2007) · Nature · doi:10.1038/nature06205 · Cited by 849
Lombardo, A., Genovese, P., Beausejour, C. M., Colleoni, S., Lee, Y.-L., Kim, K. A., Ando, D., Urnov, F. D., Galli, C., Gregory, P. D., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1353 · Cited by 845
BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo
Steegmaier, M., Hoffmann, M., Baum, A., Lénárt, P., Petronczki, M., Krššák, M., Gürtler, U., Garin-Chesa, P., Lieb, S., Quant, J., et al. (2007) · Current Biology · doi:10.1016/j.cub.2006.12.037 · Cited by 834
Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing
Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., Johnson, J. M., Lim, L., Karpilow, J., Nichols, K., et al. (2006) · RNA · doi:10.1261/rna.30706 · Cited by 789
Argonaute2 Cleaves the Anti-Guide Strand of siRNA during RISC Activation
Rand, T. A., Petersen, S., Du, F., & Wang, X. (2005) · Cell · doi:10.1016/j.cell.2005.10.020 · Cited by 784
Inhibition of respiratory viruses by nasally administered siRNA
Bitko, V., Musiyenko, A., Shulyayeva, O., & Barik, S. (2005) · Nature Medicine · doi:10.1038/nm1164 · Cited by 725
Harper, S. Q., Staber, P. D., He, X., Eliason, S. L., Martins, I. H., Mao, Q., Yang, L., Kotin, R. M., Paulson, H. L., & Davidson, B. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501507102 · Cited by 682
Self-citationChromatin structure analyses identify miRNA promoters
Ozsolak, F., Poling, L. L., Wang, Z., Liu, H., Liu, X. S., Roeder, R. G., Zhang, X., Song, J. S., & Fisher, D. E. (2008) · Genes & Development · doi:10.1101/gad.1706508 · Cited by 678
RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia
Xia, H., Mao, Q., Eliason, S. L., Harper, S. Q., Martins, I. H., Orr, H. T., Paulson, H. L., Yang, L., Kotin, R. M., & Davidson, B. L. (2004) · Nature Medicine · doi:10.1038/nm1076 · Cited by 652
Self-citationFrank-Kamenetsky, M., Grefhorst, A., Anderson, N. N., Racie, T. S., Bramlage, B., Akinc, A., Butler, D., Charisse, K., Dorkin, R., Fan, Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805434105 · Cited by 642
Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells
Czauderna, F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg393 · Cited by 623
Second-generation shRNA libraries covering the mouse and human genomes
Silva, J. M., Li, M. Z., Chang, K., Ge, W., Golding, M. C., Rickles, R. J., Siolas, D., Hu, G., Paddison, P. J., Schlabach, M. R., et al. (2005) · Nature Genetics · doi:10.1038/ng1650 · Cited by 622
Expanding the MicroRNA Targeting Code: Functional Sites with Centered Pairing
Shin, C., Nam, J.-W., Farh, K. K.-H., Chiang, H. R., Shkumatava, A., & Bartel, D. P. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.005 · Cited by 611
Inhibition of hepatitis B virus in mice by RNA interference
McCaffrey, A. P., Nakai, H., Pandey, K., Huang, Z., Salazar, F. H., Xu, H., Wieland, S. F., Marion, P. L., & Kay, M. A. (2003) · Nature Biotechnology · doi:10.1038/nbt824 · Cited by 607
McBride, J. L., Boudreau, R. L., Harper, S. Q., Staber, P. D., Monteys, A. M., Martins, I., Gilmore, B. L., Burstein, H., Peluso, R. W., Polisky, B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801775105 · Cited by 607
Self-citationSmall RNA sorting: matchmaking for Argonautes
Czech, B., & Hannon, G. J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2916 · Cited by 605
MicroRNAs Add a New Dimension to Cardiovascular Disease
Small, E. M., Frost, R. J. A., & Olson, E. N. (2010) · Circulation · doi:10.1161/circulationaha.109.889048 · Cited by 599
Dassie, J. P., Liu, X.-Y., Thomas, G. S., Whitaker, R. M., Thiel, K. W., Stockdale, K. R., Meyerholz, D. K., McCaffrey, A. P., McNamara, J. O., & Giangrande, P. H. (2009) · Nature Biotechnology · doi:10.1038/nbt.1560 · Cited by 589
Design of Noninflammatory Synthetic siRNA Mediating Potent Gene Silencing in Vivo
Judge, A. D., Bola, G., Lee, A. C. H., & MacLachlan, I. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.002 · Cited by 571
T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice
Kumar, P., Ban, H.-S., Kim, S.-S., Wu, H., Pearson, T., Greiner, D. L., Laouar, A., Yao, J., Haridas, V., Habiro, K., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.034 · Cited by 570
Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha
Zeng, Y., Yi, R., & Cullen, B. R. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600491 · Cited by 564
Förstemann, K., Tomari, Y., Du, T., Vagin, V. V., Denli, A. M., Bratu, D. P., Klattenhoff, C., Theurkauf, W. E., & Zamore, P. D. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030236 · Cited by 545
Davidson, B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., Zabner, J., Ghodsi, A., & Chiorini, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3428 · Cited by 531
Self-citationMicroRNA silencing through RISC recruitment of eIF6
Chendrimada, T. P., Finn, K. J., Ji, X., Baillat, D., Gregory, R. I., Liebhaber, S. A., Pasquinelli, A. E., & Shiekhattar, R. (2007) · Nature · doi:10.1038/nature05841 · Cited by 510
Ralph, G. S., Radcliffe, P. A., Day, D. M., Carthy, J. M., Leroux, M. A., Lee, D. C. P., Wong, L.-F., Bilsland, L. G., Greensmith, L., Kingsman, S. M., et al. (2005) · Nature Medicine · doi:10.1038/nm1205 · Cited by 506
Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target
Peer, D., Park, E. J., Morishita, Y., Carman, C. V., & Shimaoka, M. (2008) · Science · doi:10.1126/science.1149859 · Cited by 493
In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Brody, J. D., Ai, W. Z., Czerwinski, D. K., Torchia, J. A., Levy, M., Advani, R. H., Kim, Y. H., Hoppe, R. T., Knox, S. J., Shin, L. K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.9793 · Cited by 487
An mRNA m7G Cap Binding-like Motif within Human Ago2 Represses Translation
Kiriakidou, M., Tan, G. S., Lamprinaki, S., De Planell-Saguer, M., Nelson, P. T., & Mourelatos, Z. (2007) · Cell · doi:10.1016/j.cell.2007.05.016 · Cited by 467
Raoul, C., Abbas-Terki, T., Bensadoun, J.-C., Guillot, S., Haase, G., Szulc, J., Henderson, C. E., & Aebischer, P. (2005) · Nature Medicine · doi:10.1038/nm1207 · Cited by 464
Geisbert, T. W., Lee, A. C., Robbins, M., Geisbert, J. B., Honko, A. N., Sood, V., Johnson, J. C., de Jong, S., Tavakoli, I., Judge, A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60357-1 · Cited by 463
Ribonuclease activity and RNA binding of recombinant human Dicer
Provost, P. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf578 · Cited by 452
Robbins, M., Judge, A., & MacLachlan, I. (2009) · Oligonucleotides · doi:10.1089/oli.2009.0180 · Cited by 449
Synthetic shRNAs as potent RNAi triggers
Siolas, D., Lerner, C., Burchard, J., Ge, W., Linsley, P. S., Paddison, P. J., Hannon, G. J., & Cleary, M. A. (2005) · Nature Biotechnology · doi:10.1038/nbt1052 · Cited by 445
Inhibition of influenza virus production in virus-infected mice by RNA interference
Ge, Q., Filip, L., Bai, A., Nguyen, T., Eisen, H. N., & Chen, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402486101 · Cited by 444
DeVincenzo, J., Lambkin-Williams, R., Wilkinson, T., Cehelsky, J., Nochur, S., Walsh, E., Meyers, R., Gollob, J., & Vaishnaw, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912186107 · Cited by 442
Processing of Pre-microRNAs by the Dicer-1–Loquacious Complex in Drosophila Cells
Saito, K., Ishizuka, A., Siomi, H., & Siomi, M. C. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030235 · Cited by 440
Small RNAs with Imperfect Match to Endogenous mRNA Repress Translation
Saxena, S., Jónsson, Z. O., & Dutta, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307089200 · Cited by 436
Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque
Li, B.-J., Tang, Q., Cheng, D., Qin, C., Xie, F. Y., Wei, Q., Xu, J., Liu, Y., Zheng, B.-J., Woodle, M. C., et al. (2005) · Nature Medicine · doi:10.1038/nm1280 · Cited by 433
Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model
Singer, O., Marr, R. A., Rockenstein, E., Crews, L., Coufal, N. G., Gage, F. H., Verma, I. M., & Masliah, E. (2005) · Nature Neuroscience · doi:10.1038/nn1531 · Cited by 428
An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection
Palliser, D., Chowdhury, D., Wang, Q.-Y., Lee, S. J., Bronson, R. T., Knipe, D. M., & Lieberman, J. (2006) · Nature · doi:10.1038/nature04263 · Cited by 410
Interference of hepatitis C virus RNA replication by short interfering RNAs
Kapadia, S. B., Brideau-Andersen, A., & Chisari, F. V. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252783999 · Cited by 392
Kortylewski, M., Swiderski, P., Herrmann, A., Wang, L., Kowolik, C., Kujawski, M., Lee, H., Scuto, A., Liu, Y., Yang, C., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1564 · Cited by 380
Protection against lethal influenza virus challenge by RNA interference in vivo
Tompkins, S. M., Lo, C.-Y., Tumpey, T. M., & Epstein, S. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402630101 · Cited by 378
DiGiusto, D. L., Krishnan, A., Li, L., Li, H., Li, S., Rao, A., Mi, S., Yam, P., Stinson, S., Kalos, M., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000931 · Cited by 374
Structure and activity of putative intronic miRNA promoters
Monteys, A. M., Spengler, R. M., Wan, J., Tecedor, L., Lennox, K. A., Xing, Y., & Davidson, B. L. (2010) · RNA · doi:10.1261/rna.1731910 · Cited by 367
Self-citationArtificial MicroRNAs as siRNA Shuttles: Improved Safety as Compared to shRNAs In vitro and In vivo
Boudreau, R. L., Martins, I., & Davidson, B. L. (2009) · Molecular Therapy · doi:10.1038/mt.2008.231 · Cited by 359
Self-citationEfficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1
Herker, E., Harris, C., Hernandez, C., Carpentier, A., Kaehlcke, K., Rosenberg, A. R., Farese, R. V., & Ott, M. (2010) · Nature Medicine · doi:10.1038/nm.2238 · Cited by 350
Recent Advances in Lentiviral Vector Development and Applications
Mátrai, J., Chuah, M. K., & VandenDriessche, T. (2010) · Molecular Therapy · doi:10.1038/mt.2009.319 · Cited by 347
Boudreau, R. L., McBride, J. L., Martins, I., Shen, S., Xing, Y., Carter, B. J., & Davidson, B. L. (2009) · Molecular Therapy · doi:10.1038/mt.2009.17 · Cited by 339
Self-citationExploiting and antagonizing microRNA regulation for therapeutic and experimental applications
Brown, B. D., & Naldini, L. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2628 · Cited by 336
Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice
Judge, A. D., Robbins, M., Tavakoli, I., Levi, J., Hu, L., Fronda, A., Ambegia, E., McClintock, K., & MacLachlan, I. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37515 · Cited by 336
Biological Gene Delivery Vehicles: Beyond Viral Vectors
Seow, Y., & Wood, M. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.41 · Cited by 327
Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation
Thermann, R., & Hentze, M. W. (2007) · Nature · doi:10.1038/nature05878 · Cited by 316
Efficient and targeted delivery of siRNA in vivo
Shim, M. S., & Kwon, Y. J. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07904.x · Cited by 309
MacDiarmid, J. A., Mugridge, N. B., Weiss, J. C., Phillips, L., Burn, A. L., Paulin, R. P., Haasdyk, J. E., Dickson, K.-A., Brahmbhatt, V. N., Pattison, S. T., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.03.012 · Cited by 307
Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155
Chung, K.-H. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl143 · Cited by 306
A Hybrid Vector for Ligand-Directed Tumor Targeting and Molecular Imaging
Hajitou, A., Trepel, M., Lilley, C. E., Soghomonyan, S., Alauddin, M. M., Marini, F. C., Restel, B. H., Ozawa, M. G., Moya, C. A., Rangel, R., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.042 · Cited by 280
RNAi and small interfering RNAs in human disease therapeutic applications
Lares, M. R., Rossi, J. J., & Ouellet, D. L. (2010) · Trends in biotechnology · doi:10.1016/j.tibtech.2010.07.009 · Cited by 277
Rodriguez-Lebron, E., Denovan-Wright, E. M., Nash, K., Lewin, A. S., & Mandel, R. J. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.05.006 · Cited by 275
MacDiarmid, J. A., Amaro-Mugridge, N. B., Madrid-Weiss, J., Sedliarou, I., Wetzel, S., Kochar, K., Brahmbhatt, V. N., Phillips, L., Pattison, S. T., Petti, C., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1547 · Cited by 272
Short hairpin RNA–expressing bacteria elicit RNA interference in mammals
Xiang, S., Fruehauf, J., & Li, C. J. (2006) · Nature Biotechnology · doi:10.1038/nbt1211 · Cited by 271
Zhou, J., Swiderski, P., Li, H., Zhang, J., Neff, C. P., Akkina, R., & Rossi, J. J. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp185 · Cited by 267
Pfister, E. L., Kennington, L., Straubhaar, J., Wagh, S., Liu, W., DiFiglia, M., Landwehrmeyer, B., Vonsattel, J.-P., Zamore, P. D., & Aronin, N. (2009) · Current Biology · doi:10.1016/j.cub.2009.03.030 · Cited by 261
Hierarchical Rules for Argonaute Loading in Drosophila
Czech, B., Zhou, R., Erlich, Y., Brennecke, J., Binari, R., Villalta, C., Gordon, A., Perrimon, N., & Hannon, G. J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.028 · Cited by 257
Warby, S. C., Montpetit, A., Hayden, A. R., Carroll, J. B., Butland, S. L., Visscher, H., Collins, J. A., Semaka, A., Hudson, T. J., & Hayden, M. R. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.02.003 · Cited by 240
Rossi, J. J., June, C. H., & Kohn, D. B. (2007) · Nature Biotechnology · doi:10.1038/nbt1367 · Cited by 231
Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins
Boden, D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh278 · Cited by 229
Misinterpreting the Therapeutic Effects of Small Interfering RNA Caused by Immune Stimulation
Robbins, M., Judge, A., Ambegia, E., Choi, C., Yaworski, E., Palmer, L., McClintock, K., & MacLachlan, I. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.131 · Cited by 220
Sustained effects of nonallele‐specific Huntingtin silencing
Drouet, V., Perrin, V., Hassig, R., Dufour, N., Auregan, G., Alves, S., Bonvento, G., Brouillet, E., Luthi‐Carter, R., Hantraye, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21569 · Cited by 216
Cubillos-Ruiz, J. R., Engle, X., Scarlett, U. K., Martinez, D., Barber, A., Elgueta, R., Wang, Nesbeth, Y., Durant, Gewirtz, A. T., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37716 · Cited by 208
RNAi-mediated CCR5 Silencing by LFA-1-targeted Nanoparticles Prevents HIV Infection in BLT Mice
Kim, S.-S., Peer, D., Kumar, P., Subramanya, S., Wu, H., Asthana, D., Habiro, K., Yang, Y.-G., Manjunath, N., Shimaoka, M., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.271 · Cited by 207
Expression of shRNA From a Tissue-specific pol II Promoter Is an Effective and Safe RNAi Therapeutic
Giering, J. C., Grimm, D., Storm, T. A., & Kay, M. A. (2008) · Molecular Therapy · doi:10.1038/mt.2008.144 · Cited by 206
Alves, S., Nascimento-Ferreira, I., Aurégan, G., Hässig, R., Dufour, N., Brouillet, E., de Lima, M. C. P., Hantraye, P., de Almeida, L. P., & Déglon, N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003341 · Cited by 200
Grimm, D., Wang, L., Lee, J. S., Schürmann, N., Gu, S., Börner, K., Storm, T. A., & Kay, M. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43565 · Cited by 196
Bramsen, J. B., Pakula, M. M., Hansen, T. B., Bus, C., Langkjær, N., Odadzic, D., Smicius, R., Wengel, S. L., Chattopadhyaya, J., Engels, J. W., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq341 · Cited by 195
Overbaugh, J., Miller, A. D., & Eiden, M. V. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.3.371-389.2001 · Cited by 189
Silencing of human α-synuclein in vitro and in rat brain using lentiviral-mediated RNAi
Sapru, M. K., Yates, J. W., Hogan, S., Jiang, L., Halter, J., & Bohn, M. C. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.12.024 · Cited by 173
Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy
Chen, Y. H., Chang, M., & Davidson, B. L. (2009) · Nature Medicine · doi:10.1038/nm.2025 · Cited by 168
Self-citationComparison of siRNA-induced off-target RNA and protein effects
Alemán, L. M., Doench, J. G., & Sharp, P. A. (2007) · RNA · doi:10.1261/rna.352507 · Cited by 164
Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs
Boudreau, R. L., Monteys, A. M., & Davidson, B. L. (2008) · RNA · doi:10.1261/rna.1062908 · Cited by 163
Self-citationSusa, M., Iyer, A. K., Ryu, K., Choy, E., Hornicek, F. J., Mankin, H. J., Milane, L. S., Amiji, M. M., & Duan, Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010764 · Cited by 162
Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell
Sotiropoulou, G., Pampalakis, G., Lianidou, E. S., & Mourelatos, Z. (2009) · RNA · doi:10.1261/rna.1534709 · Cited by 162
CCR4-NOT Deadenylates mRNA Associated with RNA-Induced Silencing Complexes in Human Cells
Piao, X., Zhang, X., Wu, L., & Belasco, J. G. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01481-09 · Cited by 160
Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC
Hadaczek, P., Eberling, J. L., Pivirotto, P., Bringas, J., Forsayeth, J., & Bankiewicz, K. S. (2010) · Molecular Therapy · doi:10.1038/mt.2010.106 · Cited by 158
Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth
Cho, W. G., Albuquerque, R., Kleinman, M. E., Tarallo, V., Greco, A., Nozaki, M., Green, M. G., Baffi, J., Ambati, B. K., Falco, M. D., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812317106 · Cited by 155
Experimental validation of the importance of seed complement frequency to siRNA specificity
Anderson, E. M., Birmingham, A., Baskerville, S., Reynolds, A., Maksimova, E. M., Leake, D., Federov, Y., Karpilow, J. M., & Khvorova, A. (2008) · RNA · doi:10.1261/rna.704708 · Cited by 149
Anliker, B., Abel, T., Kneissl, S., Hlavatý, J., Caputi, A., Brynza, J., Schneider, I. C., Münch, R. C., Petznek, H., Kontermann, R. E., et al. (2010) · Nature Methods · doi:10.1038/nmeth.1514 · Cited by 146
Herrmann, A., Kortylewski, M., Kujawski, M., Zhang, C., Reckamp, K. L., Armstrong, B., Wang, L. Q., Kowolik, C. M., Deng, J., Figlin, R. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0736 · Cited by 138
Chadderton, N., Millington‐Ward, S., Palfi, A., O’Reilly, M., Tuohy, G., Humphries, M. M., Li, T., Humphries, P., Kenna, P. F., & Farrar, G. J. (2009) · Molecular Therapy · doi:10.1038/mt.2008.301 · Cited by 133
rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse
Machida, Y., Okada, T., Kurosawa, M., Oyama, F., Ozawa, K., & Nukina, N. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.141 · Cited by 128
Liu, C., Zhao, G., Liu, J., Ma, N., Chivukula, P., Perelman, L. A., Okada, K., Chen, Z., Gough, D., & Yu, L. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.013 · Cited by 127
Hong, C.-S., Goins, W. F., Goss, J. R., Burton, E. A., & Glorioso, J. C. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302719 · Cited by 107
Viral Vectors for Gene Transfer: Current Status of Gene Therapeutics
Heilbronn, R., & Weger, S. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_5 · Cited by 100
Silencing Primary Dystonia: Lentiviral-Mediated RNA Interference Therapy for DYT1 Dystonia
Gonzalez‐Alegre, P., Bode, N. M., Davidson, B. L., & Paulson, H. L. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3016-05.2005 · Cited by 98
Self-citationChang, J., Kuo, T.-F., Chen, Y., Chiu, C.-C., Lu, Y.-C., Li, H.-F., Shen, C.-R., & Cheng, A.-J. (2010) · Cancer Gene Therapy · doi:10.1038/cgt.2010.38 · Cited by 97
Zheng, X., Vladau, C., Zhang, X., Suzuki, M., Ichim, T. E., Zhang, Z., Li, M., Carrier, E., Garcia, B. M., Jevnikar, A. M., et al. (2009) · Blood · doi:10.1182/blood-2008-04-151191 · Cited by 95
Combinatorial RNAi Against HIV-1 Using Extended Short Hairpin RNAs
Liu, Y. P., von Eije, K. J., Schopman, N. C. T., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.176 · Cited by 94
Chung, W., Agius, P., Westholm, J. O., Chen, M. J., Okamura, K., Robine, N., Leslie, C. S., & Lai, E. C. (2010) · Genome Research · doi:10.1101/gr.113050.110 · Cited by 93
Regulated and Multiple miRNA and siRNA Delivery Into Primary Cells by a Lentiviral Platform
Amendola, M., Passerini, L., Pucci, F., Gentner, B., Bacchetta, R., & Naldini, L. (2009) · Molecular Therapy · doi:10.1038/mt.2009.48 · Cited by 91
Wu, Y., Navarro, F., Lal, A., Basar, E., Pandey, R. K., Manoharan, M., Feng, Y., Lee, S. J., Lieberman, J., & Palliser, D. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2008.12.003 · Cited by 91
MicroRNA-like off-target transcript regulation by siRNAs is species specific
Burchard, J., Jackson, A. L., Malkov, V. A., Needham, R. H. V., Tan, Y., Bartz, S. R., Dai, H. A., Sachs, A. B., & Linsley, P. S. (2009) · RNA · doi:10.1261/rna.1326809 · Cited by 90
Coexpressed RIG-I Agonist Enhances Humoral Immune Response to Influenza Virus DNA Vaccine
Luke, J., Simon, G. G., Söderholm, J., Errett, J., August, J., Gale, M., Hodgson, C. P., & Williams, J. A. (2010) · Journal of Virology · doi:10.1128/jvi.01250-10 · Cited by 83
Ely, A., Naidoo, T., & Arbuthnot, P. B. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp446 · Cited by 79
Lipophilic siRNAs mediate efficient gene silencing in oligodendrocytes with direct CNS delivery
Chen, Q., Butler, D., Querbes, W., Pandey, R. K., Ge, P., Maier, M. A., Zhang, L., Rajeev, K. G., Nechev, L. V., Koteliansky, V., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.011 · Cited by 69
Liu, Y. P., Vink, M. A., Westerink, J.-T., de Arellano, E. R., Konstantinova, P. S., ter Brake, O., & Berkhout, B. (2010) · RNA · doi:10.1261/rna.1887910 · Cited by 67
Uta Griesenbach, D., Kitson, C., Garcia, E. S., Farley, R., Singh, C., Somerton, L., Painter, H. A., Smith, R. L., Gill, D. R., Hyde, S. C., et al. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-26 · Cited by 67
A role for human Dicer in pre-RISC loading of siRNAs
Sakurai, K., Amarzguioui, M., Kim, D.-H., Alluin, J. V., Heale, B. S. E., Song, M.-S., Gatignol, A., Behlke, M. A., & Rossi, J. J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq846 · Cited by 64
Cutaneous short-interfering RNA therapy
Geusens, B., Sanders, N. N., Prow, T. W., Gele, M. V., & Lambert, J. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903304032 · Cited by 61
Hall, K., Zajdel, M. E. B., & Blair, G. E. (2010) · Biochemical Journal · doi:10.1042/bj20100766 · Cited by 58
Stein, C. S., Martins, I., & Davidson, B. L. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.11.008 · Cited by 58
Self-citationRNAi nanomedicines: challenges and opportunities within the immune system
Weinstein, S., & Peer, D. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/23/232001 · Cited by 52
Yang, X., Haurigot, V., Zhou, S., Luo, G. G., & Couto, L. B. (2010) · Hepatology · doi:10.1002/hep.23908 · Cited by 47
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure
Poller, W. C., Hajjar, R. J., Schultheiss, H.-P., & Fechner, H. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq056 · Cited by 41
Epithelial Sodium Channel Inhibition in Primary Human Bronchial Epithelia by Transfected siRNA
Caci, E., Melani, R., Pedemonte, N., Yueksekdag, G., Ravazzolo, R., Rosenecker, J., Galietta, L. J. V., & Zegarra‐Moran, O. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0456oc · Cited by 40
Tang, X., Sun, J., Wang, X.-Y., Du, L., & Liu, P. (2010) · PubMed Central · Cited by 32
HSV as a Vector in Vaccine Development and Gene Therapy
Marconi, P., Argnani, R., Epstein, A. L., & Manservigi, R. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1132-2_10 · Cited by 30
Optimization of Feline Immunodeficiency Virus Vectors for RNA Interference
Harper, S., Staber, P. D., Beck, C., Fineberg, S., Stein, C., Ochoa, D., & Davidson, B. (2006) · Journal of Virology · doi:10.1128/jvi.00958-06 · Cited by 28
Self-citationPeer, D. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.06.029 · Cited by 25
Reduced seed region-based off-target activity with lentivirus-mediated RNAi
Klinghoffer, R. A., Magnus, J., Schelter, J. M., Mehaffey, M. G., Coleman, C., & Cleary, M. A. (2010) · RNA · doi:10.1261/rna.1977810 · Cited by 24
Strategies in Designing Multigene Expression Units to Downregulate HIV-1
Zhang, J., & Rossi, J. J. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-588-0_8 · Cited by 14
Cequent Pharmaceuticals, Inc.: The Biological Pitcher for RNAi Therapeutics
Keates, A. C., Fruehauf, J. H., Xiang, S., et al. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.7.867 · Cited by 6
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Kole, R., Krainer, A. R., & Altman, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3625 · Cited by 1,152
siRNA versus miRNA as therapeutics for gene silencing
Lam, J. K. W., Chow, M. Y. T., Zhang, Y., & Leung, S. W. S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.23 · Cited by 1,081
Molecular Mechanisms of RNA Interference
Wilson, R. C., & Doudna, J. A. (2013) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-083012-130404 · Cited by 1,076
Cancer nanomedicine for combination cancer immunotherapy
Nam, J., Son, S., Park, K. S., Zou, W., Shea, L. D., & Moon, J. J. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0108-1 · Cited by 940
Metadata
- Authors
- Davidson, B. L., & McCray, P. B.
- Venue
- Nature Reviews Genetics
- Published
- 2011-04-18
- Volume
- 12
- Issue
- 5
- Pages
- 329-340
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- OpenAlex
- W1972376076
- Cited by
- 761
- References
- 162
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.